FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Date/App# patent app List of recent Dimethyl-related patents
05/21/15
20150141695
 Methods of producing para-xylene and terephthalic acid patent thumbnailMethods of producing para-xylene and terephthalic acid
The present disclosure provides methods to produce para-xylene, toluene, and other compounds from renewable sources (e.g., cellulose, hemicellulose, starch, sugar) and ethylene in the presence of a catalyst. For example, cellulose and/or hemicellulose may be converted into 2,5-dimethylfuran (dmf), which may be converted into para-xylene by cycloaddition of ethylene to dmf.
Micromidas, Inc.
05/21/15
20150141690
 Process for making dimethyl carbonate patent thumbnailProcess for making dimethyl carbonate
An eco-friendly process for making dimethyl carbonate comprising contacting methanol with carbon dioxide in the presence of a solid, calcined catalyst derived from zirconium phosphonate catalyst having molecular formula: zr(x)2-nyn.mh2o where x refers to phosphonate, y refers to hpo42− or hpo32−, n varies from 0.2 to 1.8 and m varies from 0 to 5, is disclosed.. .
Council Of Scientific & Industrial Research
05/21/15
20150141631
 Pyrazole derivative and use thereof for medical purposes patent thumbnailPyrazole derivative and use thereof for medical purposes
The present invention provides pyrazole derivatives, uses thereof for medical purposes and so on. More particularly, the present invention relates to pharmaceuticals useful for the prevention or treatment of constipation, which comprise as an active ingredient 3-(3-{4-[3-(β-d-glucopyranosyloxy)-5-isopropyl-1h-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide, or a pharmaceutically acceptable salt thereof.
Kissei Pharmaceutical Co., Ltd.
05/21/15
20150141618
 Solution-dyed protein fiber and  producing same patent thumbnailSolution-dyed protein fiber and producing same
A solution-dyed protein fiber of the present invention includes 0-100 mass % of silk fibroin and 100-0 mass % of a polypeptide derived from spider silk proteins when the protein fiber is assumed to be 100 mass %, wherein the solution-dyed protein fiber contains a solution-dyeing colorant. The fiber is obtained by: dissolving or dispersing a solution-dyeing colorant in a solvent used for a spinning solution or in dimethyl sulfoxide, thereby preparing a coloring liquid; adding a solvent to the coloring liquid in an amount necessary for a spinning solution; adding and dissolving protein powder into the solvent, thereby preparing a spinning solution; and subjecting the spinning solution to wet spinning or dry-wet spinning.
Spiber Inc.
05/21/15
20150141502
 Inhibition of leukemic stem cells by pp2a activating agents patent thumbnailInhibition of leukemic stem cells by pp2a activating agents
A method of inhibiting the growth of leukemic hematopoietic stem cells in a subject with leukemia is described. The method includes administering a therapeutically effective amount of a composition including a compound of formula i: i wherein r1 is independently selected from hydrogen and methyl; r2 is selected from the group consisting of 4,8-dimethyl-non-1-enyl, 4,8-dimethyl-nonyl, non-1-enyl, and nonanyl groups; x is a carboxyl, phosphonic, or sulfonic moiety, and n is an integer from 1 to 6, or a compound of formula ii: ii wherein r1 is a c6-c12 alkyl or c6-c12 alkoxy group; r2 is independently selected from the group consisting of hydrogen, methoxy, and hydroxyl; and r3 is an alkyl or cycloalkyl group; or a pharmaceutically acceptable salt thereof..
Ohio State Innvation Foundation
05/21/15
20150141460
 Anti-inflammatory compositions patent thumbnailAnti-inflammatory compositions
The invention relates to 3-(2′,2′-dimethylpropanoylamino)-tetrahydropyridin-2-one, and its pharmaceutical compositions and their use as a medicament intended to prevent or treat inflammatory disorders.. .
Cambridge Enterprise Limited
05/21/15
20150141253
 Crystalline form b of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione patent thumbnailCrystalline form b of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione
The present invention relates to a novel crystalline form b of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione the invention also relates to a process for the production of this crystalline form and formulations for plant protection which contains the novel crystalline form of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione.. .
Basf Se
05/21/15
20150140631
 Production of volatile dienes by enzymatic dehydration of light alkenols patent thumbnailProduction of volatile dienes by enzymatic dehydration of light alkenols
Described is a method for generating conjugated dienes through a biological process. More specifically, the application describes a method for producing conjugated dienes (for example butadiene, isoprene or dimethylbutadiene) from light alkenols via enzymatic dehydration, in particular by making use of an alkenol dehydratase..
Scientist Of Fortune, S.a.
05/21/15
20150139931
 Organopolysiloxane graft polymer patent thumbnailOrganopolysiloxane graft polymer
The present invention relates to a organopolysiloxane graft polymer including an organopolysiloxane segment as a main chain thereof and an unsaturated monomer-derived polymer segment as a side chain thereof, in which the unsaturated monomer-derived polymer segment contains a repeating unit derived from n,n-dimethyl acrylamide in an amount of not less than 50% by mass and not more than 100% by mass, and a content of the organopolysiloxane segment in the organopolysiloxane graft polymer is not less than 10% by mass and not more than 70% by mass.. .
Kao Corporation
05/21/15
20150138673
 Method for manufacturing a magnetic tape head using an ink mask formed by printing patent thumbnailMethod for manufacturing a magnetic tape head using an ink mask formed by printing
A method for forming a protective overcoat onto a tape bearing surface of a tape head used for magnetic tape recording. In order to ensure optimal surface tension and liftoff properties of the ink mask, the tape bearing surface is treated with a first application of ethanol, followed by an application of polydimethylsiloxane, followed by a second application of ethanol.
Hgst Netherlands B.v.
05/21/15
20150137029

Electrode mixture


The present invention aims to provide an electrode mixture which shows little change in viscosity even after 24 hours from the preparation of the mixture and enables production of an electrode having a high electrode density and excellent flexibility and is capable of giving excellent electric properties to the resulting cell. The present invention relates to an electrode mixture including a powdery electrode material; a binder; and an organic solvent, the binder including a fluorine-containing polymer including a polymer unit based on vinylidene fluoride and a polymer unit based on tetrafluoroethylene, the fluorine-containing polymer including the polymer unit based on vinylidene fluoride in an amount of 80.0 to 89.0 mol % based on all the polymer units, and the organic solvent being n-methyl-2-pyrolidone and/or n,n-dimethylacetamide..
Daikin Industries, Ltd.
05/21/15
20150136658

Process for removing ash and heavy hydrocarbons from coal tar


A process for removing ash and heavy hydrocarbon compounds from coal is described. The coal feed, the coal tar stream, or a coal tar fraction is contacted with a solvent to dissolve a soluble portion of the coal tar stream, the ash and heavy hydrocarbons being insoluble in the solvent, the solvent selected from the group consisting of dimethyl sulfoxide, sulfolane, dimethyl formamide, glyme, diglyme, ionic liquids, and combinations thereof, with the proviso that an anion of the ionic liquid is not a dialkylphosphate..
Uop Llc
05/14/15
20150133699

Process for the preparation of methanol and methanol-derived products from carbon oxides


A process for the preparation of methanol having the process a carbon oxides per-pass conversion equal to or higher than 65%, and a selectivity to methanol formation equal to or higher than 75% by submitting carbon dioxide, carbon monoxide or a mixture of carbon monoxide and carbon dioxide to a hydrogenation reaction using a specific metal compound and specific reaction conditions of temperature, pressure, space velocity and a specific range of molar ratio of hydrogen to carbon dioxide, of hydrogen to carbon monoxide, or of hydrogen to the mixture of carbon monoxide and carbon dioxide. It further relates to a process for converting the methanol obtained into dimethyl ether or into a mixture of (c2-c8)alkene and (c1-c8)alkane..
05/14/15
20150133659

(e)-1-(5-methoxy-2,2-dimethyl-2h-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one and analogs thereof, as well as preparation method and use thereof


The present invention relates to millepachine ((e)-1-(5-methoxy-2,2-dimethyl-2h-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one) and its analogues. The present invention provides methods for preparing these compounds, pharmaceutical compositions including these compounds, and methods of treating diseases utilizing pharmaceutical compositions including these compounds..
05/14/15
20150133654

Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide


The present invention provides methods and intermediates for the preparation of (1ar,12bs)-8-cyclohexyl-11-fluoro-n-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide (formula i), including pharmaceutically acceptable salts. The compound has activity against hepatitis c virus (hcv) and may be useful in treating those infected with hcv..
05/14/15
20150132563

Scratch-resistant liquid based coatings for glass


A sol-gel method for forming durable, scratch-resistant coatings on glass substrates. Zirconia coatings, for example, are formed from a solution of zirconium oxychloride octahydrate in an organic, polar, aprotic solvent such as dimethylformamide.
05/14/15
20150132411

Anti-cancer extract and compounds


The present invention relates to a new approach for treating a cancer or fibrosis, such as hepatocellular carcinoma, or liver fibrosis using an extract from a plant of graptopetalum sp., rhodiola sp., or echeveria sp., and prepared by extracting the plant with dimethyl sulfoxide (dmso), its fraction or the compound isolated from the extract.. .
05/14/15
20150132405

Synergistic compositions of monochlorourea and modified monochloroureas


The present invention provides synergistic combinations of monochlorourea with other biocides for controlling microbial growth in aqueous systems. It also provides synergistic combinations of dimethyl monochlorourea with other biocides for controlling growth in aqueous systems.
05/14/15
20150132233

Compositions containing theobromine and their use in treating tooth hypersensitivity


Compositions and methods for reducing oral sensitivity, increasing the systemic health of a mammal, occluding a dentinal tubule within a mammalian tooth, and/or depositing a precipitate on the surface of a mammalian tooth are provided, said compositions comprising theobromine (3,7-dimethylxanthine, the principal alkaloid in theobroma cacao).. .
05/07/15
20150126431

Method for making a tris-(2-hydroxyethyl)-methylammonium methylsulfate fatty acid ester


In a method for making a tris-(2-hydroxyethyl)-methylammonium methylsulfate fatty acid ester by quaternizing a tris-(2-hydroxyethyl)-amine fatty acid ester with dimethylsulfate the quaternizing is carried out in the presence of a solid acid scavenger. The method can provide a fabric softener active composition, comprising from 65 to 98% by weight of at least one tris-(2-hydroxyethyl)-methylammonium methylsulfate fatty acid ester, the corresponding non-quaternized tris-(2-hydroxyethyl)-amine fatty acid esters in amounts providing a total amine number of the composition of from 2 to less than 7 mg koh/g, and from 1 to 1500 ppm methanol..
Evonik Industries Ag
05/07/15
20150126045

Low temperature silicon nitride films using remote plasma cvd technology


Embodiments of the present invention generally provide methods for forming a silicon nitride layer on a substrate. In one embodiment, a method of forming a silicon nitride layer using remote plasma chemical vapor deposition (cvd) at a temperature that is less than 300 degrees celsius is disclosed.
Applied Materials, Inc.
05/07/15
20150125488

Methods and compositions involving immunostimulatory oligodeoxynucleotides


Described is an immunostimulatory oligodeoxynucleic acid molecule (odn) having the structure according to formula (i), wherein any nmp is a 2′ deoxynucleoside monophosphate or monothiophosphate, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, -6-s-deoxyguanine-, 2-dimethyl-deoxyguanosine- or n-isopentenyl-deoxyadenosine-monophosphate or -monothiophosphate, nuc is a 2′ deoxynucleoside, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, 6-s-deoxyguanine-, 2-dimethyl-deoxyguanosine- or n-isopentenyl-deoxyadenosine, any x is o or s, a and b are integers from 0 to 100 with the proviso that a+b is between 4 and 150, b and e are common groups for 5′ or 3′ ends of nucleic acid molecules, as well as a pharmaceutical composition containing such odns.. .
Valneva Austria Gmbh
04/30/15
20150119617

Process for converting oxygenates to olefins


A process for converting oxygenates to olefins comprising: a) contacting an oxygenate containing stream with a molecular sieve catalyst in an oxygenate to olefins conversion reactor under oxygenate to olefins conversion conditions to form an effluent comprising olefins; b) quenching the effluent by contacting with water; and c) contacting the quenched olefin stream with a molecular sieve to remove at least a portion of the water from the quenched olefin stream wherein the molecular sieve has a dimethyl ether adsorption capacity of less than 0.1 wt %.. .
Shell Oil Company
04/30/15
20150119596

Method for refining trimethylsilane


Disclosed is a method for refining trimethylsilane, including the steps of (1) preparing an activated carbon loaded with at least copper (ii) oxide and zinc oxide; (2) adsorbing a trimethylsilane onto the activated carbon; and (3) bringing a trimethylsilane containing silane, methylsilane or dimethylsilane as an impurity into contact with the activated carbon finished with the step (2) to remove the impurity from the trimethylsilane by adsorbing the impurity. According to this method, heat generation of the activated carbon is suppressed and impurities such as dimethylsilane, etc.
Central Glass Company, Limited
04/30/15
20150119577

Membrane separation of ionic liquid solutions


A membrane separation process using a highly fluorinated polymer membrane that selectively permeates water of an aqueous ionic liquid solution to provide dry ionic liquid. Preferably the polymer is a polymer that includes polymerized perfluoro-2,2-dimethyl-1,3-dioxole (pdd).
Cms Technologies Holdings, Inc.
04/30/15
20150119512

Release sheet


A release sheet comprising a base material and a release agent layer formed on at least one surface of the base material, wherein: the release agent layer is formed by using a release agent composition; the release agent composition contains a first polydimethylsiloxane having at least two alkenyl groups in one molecule and a second polydimethylsiloxane having at least two hydrosilyl groups in one molecule; the release agent composition contains 10.00 to 16.00 mmol of the alkenyl groups and 40.00 to 145.00 mmol of the hydrosilyl groups in a total of 30 g of the first polydimethylsiloxane and the second polydimethylsiloxane; and a molar ratio (b/a) of the hydrosilyl groups (b) to the alkenyl groups (a) is 2.0 to 15.0. According to the release sheet, it is possible to suppress the peeling force from increasing even when the release agent layer of the release sheet is exposed to the air for a long time..
Lintec Corporation
04/30/15
20150119420

Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarate


This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with dmf. This invention also provides a package comprising laquinimod and dmf for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
Teva Pharmaceutical Industries, Ltd.
04/30/15
20150119317

Oral solid dosage formulation of 1,1-dimethylethyl [(1s)-1-carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate


The present invention is directed to an oral solid dosage formulation of asunaprevir, 1,1-dimethylethyl[(1s)-1-{[(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate, and to methods of using the formulation in the treatment and/or inhibition of the hepatitis c virus and infections caused thereby.. .
Bristol-myers Squibb Company
04/30/15
20150118395

Vapor deposition of metal oxides, silicates and phosphates, and silicon dioxide


Metal silicates or phosphates are deposited on a heated substrate by the reaction of vapors of alkoxysilanols or alkylphosphates along with reactive metal amides, alkyls or alkoxides. For example, vapors of tris(tert-butoxy)silanol react with vapors of tetrakis(ethylmethylamido)hafnium to deposit hafnium silicate on surfaces heated to 300° c.
President And Fellows Of Harvard College
04/30/15
20150118174

Fragrance composition


Provided is a fragrance composition containing a compound that is highly harmonious with other various fragrances and that can impart a stronger floral feeling by being blended. A fragrance composition containing 3,6-dimethyl-heptane-2-ol.
Kao Corporation
04/30/15
20150114226

High performance hydrophobic solvent, carbon dioxide capture


Methods and compositions useful, for example, for physical solvent carbon capture. A method comprising: contacting at least one first composition comprising carbon dioxide with at least one second composition to at least partially dissolve the carbon dioxide of the first composition in the second composition, wherein the second composition comprises at least one siloxane compound which is covalently modified with at least one non-siloxane group comprising at least one heteroatom.
National Energy Technology Laboratory
04/23/15
20150112100

Bio-based terephthalate polyesters


Bio-based terephthalic acid (bio-tpa), bio-based dimethyl terephthalate (bio-dmt), and bio-based polyesters, which are produced from a biomass containing a terpene or terpenoid, such as limonene are described, as well as the process of making these products. The bio-based polyesters include poly(alkylene terephthalate)s such as bio-based poly(ethylene terephthalate) (bio-pet), bio-based poly(trimethylene terephthalate) (bio-ptt), bio-based poly(butylene terephthalate) (bio-pbt), and bio-based poly(cyclohexylene dimethyl terephthalate) (bio-pct)..
Sabic Innovative Plastics Ip B.v.
04/23/15
20150111964

Polymorphic salt of a metap-2 inhibitor and methods of making and using same


The disclosure is in part directed to crystalline forms of an oxalate salt of 6-o-(4-dimethylaminoethoxy)cinnamoyl fumagillol.. .
Zafgen, Inc.
04/23/15
20150111939

Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine


A pharmaceutical dosage form for administration twice daily, once daily or less frequently, which contains 6′-fluoro-(n-methyl- or n,n-dimethyl)-4-phenyl-4′,9′-dihydro-3′h-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine or a physiologically acceptable salt thereof.. .
Gruenenthal Gmbh
04/23/15
20150111927

Pharmaceutical diagnostic


The present invention relates to selective cancer treatment regimes based on assaying for the presence or absence of a glutamine or a nucleic acid that encodes glutamine at position 859 of the catalytic p110α subunit of pi3k; methods for producing a transmittable form of information for predicting the responsiveness of patient to (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide), or a pharmaceutically acceptable salt thereof; and a kit thereof.. .
Novartis Ag
04/23/15
20150111904

Pharmaceutical combination of mek inhibitor and b-raf inhibitors


A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or solvate thereof, with a b-raf inhibitor, particularly n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or b-raf is beneficial, eg. Melanoma..
Glaxosmithkline Llc
04/23/15
20150111724

Visible light responsive photocatalyst by hydrophilic modification using polymer material and a preparing the same


According to the present invention, the tio2 surface having an increased visible light absorbance due to nitrogen-doping has been modified into a hydrophilic surface using polydimethylsiloxane (pdms), i.e., a silicon-carbon precursor, and thereby significantly improved the removal efficiency of environmental contaminants under visible light. Additionally, the photocatalyst of the present invention for removing environmental contaminants is applicable to environment-friendly fields such as removal of volatile organic compounds, air purification, wastewater treatment and sterilization, and enables to remove contaminants by being attached to the surfaces of external walls of buildings, construction materials, glass windows, sound-absorbing walls, road facilities, signboards, etc., while preventing damages by sunlight..
04/23/15
20150111229

Method for searching for inhibitor of odor cause by furaneol


It is intended to identify a substance inhibiting an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone. The present invention provides a method for searching for an inhibitor of an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone, comprising: adding a test substance and 2,5-dimethyl-4-hydroxy-3(2h)-furanone to an olfactory receptor or5k1 or a polypeptide having at least 80% amino acid sequence identity thereto; measuring the response of the olfactory receptor or the polypeptide to 2,5-dimethyl-4-hydroxy-3(2h)-furanone; and identifying a test substance inhibiting the response of the olfactory receptor or the polypeptide, on the basis of the measured response..
Kao Corporation
04/23/15
20150111099

Lithium ion battery cathode additive, fabrication method thereof, lithium ion battery cathode sheet and lithium ion battery


A lithium ion battery cathode additive includes a core-shell coating structure formed by elemental lithium powder and a polymer coated on the surface of the elemental lithium powder, where the polymer can dissolve in a carbonic ester solvent, the polymer cannot react with n,n-dimethylformamide (dmf), n,n-dimethylacetamide (dmac), n-2-methyl pyrrolidone (nmp), tetrahydrofuran (thf), acetone or methanol, and the polymer exists stably at a temperature of 0-150° c. The lithium ion battery cathode additive may be added in a lithium ion battery cathode material as a lithium source, for compensating lithium consumption of a battery cathode in a first-time charge-discharge process.
Huawei Technologies Co., Ltd.
04/23/15
20150111038

Amides of 2-amino-4-arylthiazole compounds and their salts


The present disclosure is directed to salts of n-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-5-yl)acetamide and process for the preparation thereof (formula ii).. .
Glenmark Pharmaceuticals S.a.
04/23/15
20150110731

Inhibitor of odor caused by furaneol


Provided is a substance inhibiting an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone. An inhibitor of an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone, comprising a substance inhibiting the response of an olfactory receptor or5k1 as an active ingredient..
Kao Corporation
04/23/15
20150108416

Coating solution for forming light-absorbing layer, and producing coating solution for forming light-absorbing layer


A coating solution for forming a light-absorbing layer of a czts solar cell, including a hydrazine-coordinated cu chalcogenide complex component (a), a hydrazine-coordinated sn chalcogenide complex component (b) and a hydrazine-coordinated zn chalcogenide complex component (c) dissolved in dimethylsulfoxide; and a method of producing a coating solution forming a light-absorbing layer a czts solar cell, including preparing dimethylsulfoxide having a hydrazine-coordinated cu chalcogenide complex dissolved therein as a first solution, dissolving a hydrazine-coordinated sn chalcogenide complex in dimethylsulfoxide to obtain a second solution, dissolving a hydrazine-coordinated zn chalcogenide complex in dimethylsulfoxide to obtain a third solution, and mixing together the first solution, the second solution and the third solution.. .
Tokyo Ohka Kogyo Co., Ltd.
04/23/15
20150107844

Well treatment fluids containing biodegradable zirconium crosslinker and methods of using the same


A fracturing fluid containing a hydratable viscosifying polymer and a zirconium acetylacetonate crosslinker provides a green alternative to conventional systems. The zirconium aceylacetonate is dissolved in benzyl alcohol or in a mixture of benzyl alcohol and 2,2-dimethyl-1,3-dioxolan-4(yl)-methanol.
Baker Hughes Incorporated
04/16/15
20150105567

Optically active axially chiral alpha-allenic alcohol, synthesis method and use thereof


The present invention relates to an optically active axially chiral α-allenic alcohol, a synthetic method and use thereof. A method of preparing a high optically active chiral α-allenic alcohol by using propargyl alcohol, aldehyde and chiral α,α-diphenyl-l-prolinol under the protection of tert-butyldimethylsilyl with a mediator zinc bromide.
Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences
04/16/15
20150105522

Composite composition of inorganic oxide particles and silicone resin, manufacturing the same, transparent composite, and manufacturing the same


A method of manufacturing a composite composition, having: bonding a dispersant to the surfaces of inorganic oxide particles to provide dispersibility in a hydrophobic solvent to the inorganic oxide particles, and then dispersing the inorganic oxide particles in a hydrophobic solvent; substituting the dispersant bonded to the surfaces of the inorganic oxide particles with a surface modifier, which is a polydimethylsiloxane-skeleton polymer having one functional group at one terminal end, in the hydrophobic solvent in which the organic oxide particles are dispersed to bond the functional group of the polydimethylsiloxane-skeleton polymer to the surfaces of the inorganic oxide particles; and conjugating a silicone resin and the inorganic oxide particles obtained in the previous step, wherein the surface thereof is modified by bonding the polydimethylsiloxane-skeleton polymer having one functional group at one terminal end thereof, to obtain a composite composition.. .
Kyoto University
04/16/15
20150105479

Catalytically active body for the synthesis of dimethyl ether from synthesis gas


The invention relates to a catalytically active body for the synthesis of dimethyl ether from synthesis gas. In particular, the invention relates to an improved catalytically active body for the synthesis of dimethyl ether, whereby the components of the active body comprise a methanol active component and an acid component comprising a zeolitic material being crystallized by means of one or more alkenyltrialkylammonium cation r1r2r3r4n+-containing compounds as structure directing agent.
Basf Se
04/16/15
20150105355

4-dedimethylamino tetracycline compounds


The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression..
Paratek Pharmaceuticals, Inc.
04/16/15
20150105353

Stable composition for controlling biological growth and using same in oil field applications


A stabilized composition is disclosed which contains at least two biocides, particularly at least two non-oxidizing biocides. In one embodiment, the composition contains a phosphonium sulfate compound combined with a dialkyl dimethyl quaternary amine compound.
Lonza Inc.
04/16/15
20150105305

High elastohydrodynamic shear strength fluid compositions


A lubrication fluid including cyclic hydrocarbons in combination with dimethylsilicone fluids and/or di-alkyl or di-cycloalkyl or alkyl-cycloalkyl, or mixtures thereof, and di-end-capped polypropylene oxides or highly branched esters to produce very high traction elastohydrodynamic (ehd) traction fluids and to modify the low temperature viscometric properties of the mixed fluids without adversely affecting the very high elastohydrodynamic shear strength or traction coefficients of the very high shear strength cyclic hydrocarbon fluid in the resulting mixed fluids with improved low temperature viscosity.. .
Santolubes Incorporation
04/16/15
20150104378

Synthesis of borosilicate ton-framework type molecular sieves


A method is disclosed for synthesizing borosilicate ton-framework type molecular sieves in a hydroxide media using a 1,3-dimethylimidazolium cation or a 1,4-bis(n-methylimidazolium)butane dication as a structure directing agent.. .
04/09/15
20150099913

Methanol conversion process


A methanol conversion process comprises contacting a feedstream comprising methanol, optionally with dimethyl ether or other oxygenates with a catalyst comprising a physical mixture of a molecular sieve, preferably an intermediate or small pore size zeolite such as an mfi zeolite, with a basic metal oxide to provide extended catalyst cycle life by reducing the incidence of coke formation. The process may be applied to the methanol-to-gasoline (mtg), methanol to distillate (mod), methanol-to-olefins (mto), methanol-to-chemicals (mtc) and combination processes such as the mto/ocp process..
Exxonmobil Research And Engineering Company
04/09/15
20150099889

Method for preparation of medetomidine with chloroacetone


The invention discloses a method for the preparation of medetomidine starting from 1-bromo 2,3-dimethylbenzene and chloroacetone.. .
Lonza Ltd
04/09/15
20150099760

Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof


This invention relates to (1) process of making 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and salts thereof; (2) novel salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide; (3) pharmaceutical compositions comprising the same; and (4) methods of treatment using the same.. .
Novartis Ag
04/09/15
20150099736

Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity


Wherein r1, r2, r5 and r6 are independently selected from hydrogen, hydroxy, methyl, trifluoromethyl, hydroxymethyl, methoxy, trifluoromethoxy, methylamino and dimethylamino; r3, and r4 are independently selected from hydrogen, hydroxy, c1-c3 alkyl, fluoro-(c1-c3)-alkyl, hydroxy-(c1-c3)-alkyl, c1-c3 alkoxy, fluoro-(c1-c3)-alkoxy, hydroxy-(c1-c3)-alkoxy, —n(r11)—r12, -alk-n(r11)—r12, —o-alk-n(r11)—r12, —c(═o)oh, carboxy-(c1-c3)-alkyl, or —c(═o)—nh—r13; alk is a straight or branched chain divalent c1-c6 alkylene radical; r7 and r8 are independently selected from hydrogen, hydroxy, or c1-c3 alkoxy; x is a straight chain divalent c1-c3 alkylene radical, optionally substituted on one or more carbons by r9 and/or r10; w is selected from —c(═o)—n(—r16)— or —n(—r17)—c(═o)—; y is hydrogen, c1-c3 alkyl, c1-c3 alkoxy, or halo; and q is selected from optionally substituted phenyl, optionally substituted cyclohexyl, or an optionally substituted 6-membered monocyclic heteroaryl ring.. .
04/09/15
20150099724

Novel crystals and process of making 5-(-methyl)-2-methoxy-benzoic acid


The present invention relates to a novel crystals of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid and methods of making the zwitterion of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid.. .
Furiex Pharmaceuticals, Inc.
04/09/15
20150099631

Crystalline form a of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione


The present invention relates to a novel crystalline form a of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione. The invention also relates to a process for the production of this crystalline form and formulations for plant protection which contains the novel crystalline form of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione..
Basf Se
04/09/15
20150099227

Resin for toner and toner


The present invention provides a crystalline polyester resin for toner that has, when used as a resin for toner, a sharp melt property, excellent fixing performance and blocking property and a preferable charging performance. Provided is a crystalline polyester resin for toner, which is obtained by condensation polymerization of a dicarboxylic acid component containing at least one compound selected from the group consisting of terephthalic acid, 2,6-naphthalenedicarboxylic acid and derivatives thereof, and a diol component containing at least one compound selected from the group consisting of 2-methyl-1,3-propanediol, 2,2-dimethyl-1,3-propanediol and derivatives thereof, the crystalline polyester resin having a weight-average molecular weight of not less than 5000 and not more than 50000..
Canon Kabushiki Kaisha
04/09/15
20150099072

Method for forming ti-containing film by peald using tdmat or tdeat


A method for forming a ti-containing film on a substrate by plasma-enhanced atomic layer deposition (peald) using tetrakis(dimethylamino)titanium (tdmat) or tetrakis(diethylamino)titanium (tdeat), includes: introducing tdmat and/or tdeat in a pulse to a reaction space where a substrate is placed; continuously introducing a nh3-free reactant gas to the reaction space; applying rf power in a pulse to the reaction space wherein the pulse of tdmat and/or tdeat and the pulse of rf power do not overlap; and repeating the above steps to deposit a ti-containing film on the substrate.. .
Asm Ip Holding B.v.
04/09/15
20150098915

Novel surfactant-free self-reversible reverse latex, and use of same as a thickening agent in a cosmetic composition


Disclosed is a self-reversible reverse latex including: a) 25-80% by mass of a cross-linked anionic polyelectrolyte (p), resulting from the polymerisation, for 100 mole percent: i)—of a molar proportion 30% and 95% of monomeric units from at least one monomer including a free, partially- or totally-salified strong acid function; and ii)—of a molar proportion >0% and <5% of at least one monomer with diethylenic or polyethylenic crosslinking; b) 0.5-10% by mass of a terpolymer of stearyl methacrylate, pentacosaethoxylated behenyl methacrylate and n,n-dimethylacrylamide, resulting from the polymerisation, for 100 mole percent: of 80-95 mole percent of stearyl methacrylate, of 2.5-10 mole percent of n,n-dimethylacrylamide, and of 2.5-10 mole percent of pentacosaethoxylated behenyl methacrylate, c) 5-40% by mass of at least one oil, and d) 0.1-40% by mass of water; method of preparing same and use thereof as a thickener.. .
Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic
04/02/15
20150094497

Reaction system and process for preparing polymethoxy dimethyl ether


The invention relates to a reaction system and process for continuously preparing polymethoxy dimethyl ether (dmm3-8) by a continuous acetalization reaction between an aqueous formaldehyde solution or paraformaldehyde and methanol in the presence of a functionalized acidic ionic liquid as a catalyst. The reaction system of the invention preferably comprises a formaldehyde-concentrating unit, a vacuum-drying unit, an acetalization reaction unit, a product-separating unit and a catalyst-regenerating unit.
Suzhou Ost Advanced Materials Co., Ltd.
04/02/15
20150094321

Combination


The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and n-{(1s)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
Glaxosmithkline Llc
04/02/15
20150094316

Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine


Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine are provided. .
H. Lundbeck A/s
04/02/15
20150094283

Combination


The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and n-{(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
Glaxosmithkline Llc


Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         













0.5938

3287

3 - 0 - 73